Indivior To Participate In Bank of America Global Healthcare Conference 2023

Indivior PLC (LSE: INDV) has announced its participation in the Bank of America Global Healthcare Conference 2023, taking place in Las Vegas on May 10 and 11.

Rhea-AI Summary

Indivior PLC (LSE: INDV) has announced its participation in the Bank of America Global Healthcare Conference 2023, taking place in Las Vegas on May 10 and 11. CEO Mark Crossley will conduct 1x1/group meetings and present on May 10 at 5:00 p.m. PDT (8:00 p.m. EST). Interested investors can contact their Bank of America representative to schedule meetings. The presentation will be accessible through www.indivior.com and via a webcast link. Indivior is dedicated to developing treatments for substance use disorders (SUD) and serious mental illnesses, aiming to provide global access to evidence-based treatment for these chronic conditions. The company is headquartered in Richmond, VA, and has operations in 39 countries worldwide.

Argus Session date unavailable

+2.43% session move Open Argus

Details

News Market Reaction – INVVY

The recorded move for INVVY in the trading session of this news was +2.43%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SLOUGH, UK and RICHMOND, Va., April 25, 2023 /PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor event:

• Bank of America Global Healthcare Conference 2023 – Las Vegas
  Mark Crossley, CEO, will host 1x1/group meetings on Wednesday and Thursday, May 10^th and 11^th and host a presentation Wednesday May 10^th at 5:00 p.m. US PDT (8:00 p.m. US EST). Investors can contact their Bank of America representative to schedule a meeting. The presentation will be available at www.indivior.com and can also be viewed using the following webcast link: https://bofa.veracast.com/webcasts/bofa/healthcare2023/idvYkp0I.cfm

About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in 39 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-bank-of-america-global-healthcare-conference-2023-301806890.html

SOURCE Indivior PLC

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Indivior present at the Bank of America Healthcare Conference 2023?

Indivior will present on May 10, 2023, at 5:00 p.m. PDT.

Where is the Bank of America Global Healthcare Conference 2023 held?

The conference will be held in Las Vegas.

Who is the CEO of Indivior participating in the conference?

The CEO of Indivior is Mark Crossley.

How can investors access Indivior's presentation at the conference?

Investors can access the presentation via www.indivior.com and through a specific webcast link.

What does Indivior focus on developing?

Indivior focuses on developing medicines for substance use disorders and serious mental illnesses.